The Observational Medical Outcomes Partnership (OMOP) is a public-private partnership designed to inform the appropriate use of observational data for studying the real-world effects of medical products. OMOP is a multi-year methodological research initiative that has developed a network of administrative claims and electronic health records databases and established a community of methodologists to test the feasibility and utility of large-scale observational analyses. Each year, OMOP holds an annual symposium to publicly share insights from the partnership's ongoing research with all interested stakeholders.
Moderator:
Abraham G. Hartzema PharmD, MSPH, PhD, FISPE, OMOP Research Investigator Professor and Eminent Scholar, Perry A. Foote Chair in Health Outcomes and Pharmacoeconomics; Professor, Department of Epidemiology and Biostatistics, College of Public Health and Health Professions, University of Florida
Panelists:
Michael Berkwits, MD, MSCE, Deputy Editor, Annals of Internal Medicine, Adjunct Associate Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania
Sharon-Lise T. Normand, PhD, Professor of Health Care Policy, Harvard Medical School, and Professor, Department of Statistics, Harvard School of Public Health
Robert T. O'Neill, PhD, Senior Statistical Advisor, CDER, US Food and Drug
Administration
Miriam Sturkenboom, PhD, Professor in Pharmacoepidemiology, Department of
Medical Informatics, Erasmus University Medical Center
